DHX30 syndrome

DHX30 syndrome
SpecialtyMedical genetics
FrequencyRare

DHX30 syndrome is a rare genetic disorder affecting brain development caused by various pathogenic variants in the gene encoding the ATP-dependent RNA helicase DHX30 (commonly called DHX30). DHX30 syndrome is classified as a neurodevelopmental disorder and is characterized by variable clinical severity. Pathogenic missense variants within its conserved helicase core motifs cause global developmental delay, intellectual disability, severe speech impairment, gait abnormalities, low muscle tone, differences in brain structure, eye misalignment, autistic features, and seizures. Symptoms and their severity vary widely across individuals. Many affected individuals show symptoms in infancy. The majority of individuals with DHX30 syndrome have a non-familial (de novo) mutation in the DHX30 gene that causes a disruption in the ability of the encoded RNA helicase enzyme (also called DHX30) to perform its helicase function properly. Many individuals are not diagnosed until after they miss developmental milestones or begin to have seizures, and diagnosis requires genetic sequencing. No cure for DHX30 syndrome is currently available, and treatment focuses on alleviating symptoms.

NEDMIAL (Neurodevelopmental Disorder characterized with severe Motor Impairment and Absent Language, OMIM* 617804) is a name that has been used for this disorder, but is no longer considered appropriate because some individuals learn to speak and walk.1,2